Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,530 | 491 | 98.9% |
| Education | $84.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,528 | 171 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $756.76 | 58 | $0 (2024) |
| Janssen Biotech, Inc. | $541.61 | 44 | $0 (2024) |
| PFIZER INC. | $380.87 | 32 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $350.44 | 28 | $0 (2024) |
| Celgene Corporation | $322.94 | 16 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $291.58 | 4 | $0 (2024) |
| UCB, Inc. | $276.62 | 21 | $0 (2022) |
| Gilead Sciences, Inc. | $241.41 | 10 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $212.81 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,818 | 83 | ABBVIE INC. ($522.54) |
| 2023 | $1,215 | 71 | AbbVie Inc. ($561.86) |
| 2022 | $887.08 | 54 | ABBVIE INC. ($597.43) |
| 2021 | $665.40 | 40 | AbbVie Inc. ($202.38) |
| 2020 | $370.34 | 22 | AbbVie Inc. ($57.97) |
| 2019 | $841.88 | 83 | AbbVie, Inc. ($167.50) |
| 2018 | $900.59 | 59 | AbbVie, Inc. ($207.77) |
| 2017 | $916.14 | 80 | AbbVie, Inc. ($210.38) |
All Payment Transactions
492 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.05 | General |
| Category: Neuroscience | ||||||
| 09/26/2024 | Olympus America Inc. | Olympus (Device) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Endotherapy | ||||||
| 09/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Immunology | ||||||
| 09/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.79 | General |
| Category: VIROLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Neuroscience | ||||||
| 09/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: Neuroscience | ||||||
| 09/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Olympus America Inc. | Olympus (Device) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: Endotherapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,202 | 2,036 | $703,266 | $158,093 |
| 2022 | 17 | 1,101 | 1,784 | $615,776 | $135,154 |
| 2021 | 16 | 991 | 1,479 | $507,508 | $124,435 |
| 2020 | 15 | 666 | 841 | $341,583 | $78,849 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 186 | 436 | $92,170 | $42,022 | 45.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 196 | 696 | $99,458 | $18,275 | 18.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 107 | 110 | $45,384 | $15,434 | 34.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 67 | 70 | $74,073 | $14,695 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 151 | $32,486 | $14,650 | 45.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 125 | 126 | $117,876 | $13,923 | 11.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 116 | 120 | $96,655 | $8,467 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $15,581 | $5,598 | 35.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 27 | 27 | $25,259 | $4,724 | 18.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 38 | 63 | $11,952 | $4,163 | 34.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $12,888 | $3,189 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 52 | $9,100 | $3,172 | 34.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $14,917 | $2,606 | 17.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 18 | 19 | $40,879 | $2,023 | 4.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $7,000 | $1,966 | 28.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 30 | 32 | $4,218 | $1,714 | 40.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 23 | $3,370 | $1,473 | 43.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 190 | 459 | $97,033 | $37,109 | 38.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 120 | 123 | $50,747 | $19,038 | 37.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 157 | 513 | $73,308 | $12,999 | 17.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 56 | 56 | $59,258 | $11,518 | 19.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 137 | 140 | $112,764 | $10,850 | 9.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 77 | 77 | $72,035 | $7,658 | 10.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 106 | $17,697 | $7,062 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 69 | $14,845 | $6,005 | 40.5% |
About Dr. Jennifer Sinclair, MD
Dr. Jennifer Sinclair, MD is a Internal Medicine healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1295900108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Sinclair, MD has received a total of $7,614 in payments from pharmaceutical and medical device companies, with $1,818 received in 2024. These payments were reported across 492 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,530).
As a Medicare-enrolled provider, Sinclair has provided services to 3,960 Medicare beneficiaries, totaling 6,140 services with total Medicare billing of $496,531. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Orange City, FL
- Active Since 04/23/2008
- Last Updated 11/04/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1295900108
Products in Payments
- SKYRIZI (Biological) $674.13
- RINVOQ (Biological) $589.53
- STELARA (Biological) $455.85
- ENTYVIO (Biological) $423.45
- ZEPOSIA (Drug) $348.99
- XELJANZ (Drug) $321.79
- VOQUEZNA (Drug) $291.58
- Cimzia (Drug) $276.62
- XIFAXAN (Drug) $272.15
- HUMIRA (Biological) $263.69
- LINZESS (Drug) $241.32
- MAVYRET (Drug) $237.88
- Humira (Biological) $208.05
- Entyvio (Biological) $177.78
- OCALIVA (Drug) $144.14
- EndoClot PHS (Device) $141.39
- Creon (Drug) $138.66
- Mavyret (Drug) $137.19
- DUPIXENT (Biological) $131.95
- ZENPEP (Drug) $126.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Orange City
Mr. Godson Oguchi, M.d, M.D
Internal Medicine — Payments: $75,699
Dr. Bushra Ajaz, Md, MD
Internal Medicine — Payments: $13,085
Mr. Laith Derbas, Md, MD
Internal Medicine — Payments: $8,030
Dr. Kaleem Ahmed, M.d, M.D
Internal Medicine — Payments: $3,836
Glenda Rosa Gonzalez, Md, MD
Internal Medicine — Payments: $3,297
Ahmed Elbanna, D.o, D.O
Internal Medicine — Payments: $2,718